CHRONIC HYPOPARATHYROIDISM
Clinical trials for CHRONIC HYPOPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HYPOPARATHYROIDISM trials appear
Sign up with your email to follow new studies for CHRONIC HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart risk in hypoparathyroidism: could a Once-Daily injection protect arteries?
Disease control OngoingThis study investigates whether long-acting parathyroid hormone (PTH) analogues can reduce signs of early heart and blood vessel damage in adults with chronic hypoparathyroidism. Researchers will compare artery stiffness and heart function in people taking the PTH analogue palope…
Matched conditions: CHRONIC HYPOPARATHYROIDISM
Sponsor: National and Kapodistrian University of Athens • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug could free patients from daily calcium pills
Disease control OngoingThis phase 3 trial tests eneboparatide, a lab-made hormone, in 165 adults with chronic hypoparathyroidism. The goal is to see if it can help patients stop taking high-dose calcium and vitamin D supplements while keeping calcium levels normal. Participants receive either the drug …
Matched conditions: CHRONIC HYPOPARATHYROIDISM
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC